Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase versus placebo in normotensive acute pulmonary embolism with right ventricular dysfunction
2006-005328-18Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pulmonary embolism (PE) comparing Metalyse plus standard treatment with Placebo plus standard treatment (2 arms). Primary endpoint: Primary efficacy endpoint. Started Mar 2007; status: completed.
02
Drugs
tenecteplase
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on 2006-005328-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005328-18.